Inexpert use of IVDs in Vietnam behind high proportion of medical errors
This article was originally published in Clinica
Health experts in Vietnam say that local private labs and clinics need greater regulation because errors in tests conducted at these centres have reached unacceptable levels. Fully 68% of medical errors are said to be associated with diagnostic testing, delegates at a recent conference in Ha Noi were told.
You may also be interested in...
Grail announced it will enroll about 6,200 people in an interventional, multi-center study evaluating its multi-cancer early-detection blood test. This is the first time health care providers will use this test to help guide patient care.
As of 5 February, the Scientific Committee on Consumer Safety is evaluating use of titanium dioxide – now officially classified as a Category 2 carcinogen in the EU – in cosmetic products that can expose consumers by way of inhalation. Without a favorable SCCS opinion, the ingredient’s use in those contexts will be banned under Article 15 of the Cosmetics Regulation.
Nanobiotix’s CEO outlines to Scrip how the biotech plans to develop and expand its lead asset into multiple cancer indications, and create a blockbuster.